Bruker Spatial Biology, a division of Bruker Corporation announced that it will expand its collaboration with Noetik Inc., following their prior study of more than 3500 patient samples with the CosMx®? Spatial Molecular Imager (SMI). CosMx SMI powers Noetik's pre-training and scaling of bio- foundation models to perform complex genome-wide simulations of human cellular- and tissue-level biology to enable diverse therapeutics applications.
To develop self-supervised AI, Noetik leverages the CosMx SMI platform to generate the largest and most biologically complete single-cell and subcellular spatial transcriptomic and multiomic datasets in oncology. Noetik is now further imaging thousands of additional patients with the CosMx whole transcriptome assay to train their world models that learn from human tissue data. This collaboration builds on Bruker's best-in-class spatial biology portfolio, including CosMx SMI, AtoMx®?
SIP, CellScape?? XR, GeoMx®? DSP and PaintScape??
platform, which together support high fidelity data generation for discovery and translational research.
